Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes

Patients with lower‐risk myelodysplastic syndromes (LR‐MDS) as defined by the International Prognostic Scoring System (IPSS) have more favorable prognosis in general, but significant inter‐individual heterogeneity exists. In this study, we examined the molecular profile of 15 MDS‐relevant genes in 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lingxu, Luo, Yingwan, Zhu, Shuanghong, Wang, Lu, Ma, Liya, Zhang, Hua, Shen, Chuying, Yang, Wenli, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004535/
https://www.ncbi.nlm.nih.gov/pubmed/31804030
http://dx.doi.org/10.1111/cas.14270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004535/
https://www.ncbi.nlm.nih.gov/pubmed/31804030
http://dx.doi.org/10.1111/cas.14270

Ejemplares similares